OZ Management, Royce & Associates Increase Stakes In Two Companies Ahead Of Earnings

Endo International

According to a Schedule 13G filed with the SEC on Monday, hedge fund OZ Management has boosted its exposure to Endo International by 31.8 percent. The firm had last disclosed ownership of 8,839,839 of the company’s Ordinary Shares, which made it one of the top five institutional investors of record.

Now, following the purchase of 2,813,080 shares, the fund holds 11,652,919 Ordinary Shares, representing 5.15 percent of the total shares outstanding.

Related Link: Why Are So Many Key Hedge Funds Closing Down?

Having felt the pressure of the debate around healthcare and drug costs, shares of Endo are down roughly 14 percent year-to-date, creating a buying opportunity for long-term investors.

Other major investment firms that recently disclosed big stakes in the stock include TPG Group Holdings (SBS) Advisors, which acknowledged holding 17,182,136 shares as of October 10, and Janus Capital Management, which declared ownership of 17,240,921 shares (worth more than $1.3 billion) as of the end of the second quarter of the year.

Among hedge funds, Larry Robbins’ Glenview Capital Management could also be highlighted. The fund last said to own 8,837,703 Ordinary Shares, or roughly 4.25 percent of the company.

Perceptron

On Tuesday, hedge fund Royce & Associates disclosed a 27.9 percent surge in its exposure to Perceptron. The firm said it held, as of Tuesday, a passive stake comprising 948,280 of Common Stock, or 10.14 percent of the total shares outstanding.

This wage makes of Royce & Associates the second largest institutional investor in the company, only trailing John W. Rogers’ Ariel Investments, which last declared holding 1,372,183 shares of the micro-cap company.

Disclosure: Javier Hasse holds no positions in any of the securities mentioned above.

Image Credit: Public Domain